S4182 CMV Esophagitis Presenting as an Esophageal Mass in an Immunocompromised Patient

Introduction: Cytomegalovirus (CMV) esophagitis is a significant gastrointestinal manifestation of CMV infection, particularly in immunocompromised individuals, ranking as the third leading cause of infectious esophagitis. While typically characterized by odynophagia, dysphagia, and endoscopic findings of shallow, linear ulcers, atypical presentations can occur. Diagnosis relies on histopathological identification of CMV inclusion bodies, as serology can be unreliable in severely immunosuppressed states. This report details an unusual case of CMV esophagitis presenting as a polypoid esophageal mass. Case Description/Methods: A 68-year-old woman with a history of breast cancer undergoing active chemotherapy (last cycle 10 days prior), schizophrenia, and chronic cannabis use presented with worsening altered mental status and recurrent nausea and vomiting. She had multiple recent admissions for similar symptoms with only partial relief from proton pump inhibitors and sucralfate. Laboratory findings included leukocytosis (WBC 25.3 K/uL), iron-deficiency anemia (Hb dropped from 7.4 to 6.9 g/dL, requiring transfusion), thrombocytosis (Plt 661 K/uL), and elevated liver enzymes (ALT 71 U/L, ALP 193 U/L). Computed tomography chest revealed lower esophageal wall thickening with paraesophageal fluid, raising suspicion for esophagitis or malignancy. Esophagogastroduodenoscopy revealed LA Grade D esophagitis, an oozing esophageal ulcer, and a distinct polypoid mucosal mass in the lower esophagus. Biopsies of the mass showed ulcerated granulation tissue with acute inflammation and were positive for CMV via immunostaining. The patient was treated with oral valganciclovir, alongside continued proton pump inhibitors and sucralfate therapy. Discussion: This case highlights an atypical presentation of CMV esophagitis as an esophageal mass, contrasting with its more common ulcerative manifestations. In immunocompromised patients presenting with esophageal masses, CMV infection should be considered in the differential diagnosis to avoid misdiagnosis with malignancy or other conditions. Prompt and accurate diagnosis is crucial, as antiviral therapy is effective. This case underscores the importance of thorough histopathological evaluation, including CMV immunostaining, in such clinical scenarios.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001144188.98624.fb
Primary Topic
Cytomegalovirus and herpesvirus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S4182 CMV Esophagitis Presenting as an Esophageal Mass in an Immunocompromised Patient

Seyma Bayram, Amit Sohagia, M Ammar Kalas, Mehmet Talha Bayram
The American Journal of Gastroenterology
Cytomegalovirus and herpesvirus research
article

S4182 CMV Esophagitis Presenting as an Esophageal Mass in an Immunocompromised Patient

Seyma Bayram, Amit Sohagia, M Ammar Kalas, Mehmet Talha Bayram
article en

Abstract

Introduction: Cytomegalovirus (CMV) esophagitis is a significant gastrointestinal manifestation of CMV infection, particularly in immunocompromised individuals, ranking as the third leading cause of infectious esophagitis. While typically characterized by odynophagia, dysphagia, and endoscopic findings of shallow, linear ulcers, atypical presentations can occur. Diagnosis relies on histopathological identification of CMV inclusion bodies, as serology can be unreliable in severely immunosuppressed states. This report details an unusual case of CMV esophagitis presenting as a polypoid esophageal mass. Case Description/Methods: A 68-year-old woman with a history of breast cancer undergoing active chemotherapy (last cycle 10 days prior), schizophrenia, and chronic cannabis use presented with worsening altered mental status and recurrent nausea and vomiting. She had multiple recent admissions for similar symptoms with only partial relief from proton pump inhibitors and sucralfate. Laboratory findings included leukocytosis (WBC 25.3 K/uL), iron-deficiency anemia (Hb dropped from 7.4 to 6.9 g/dL, requiring transfusion), thrombocytosis (Plt 661 K/uL), and elevated liver enzymes (ALT 71 U/L, ALP 193 U/L). Computed tomography chest revealed lower esophageal wall thickening with paraesophageal fluid, raising suspicion for esophagitis or malignancy. Esophagogastroduodenoscopy revealed LA Grade D esophagitis, an oozing esophageal ulcer, and a distinct polypoid mucosal mass in the lower esophagus. Biopsies of the mass showed ulcerated granulation tissue with acute inflammation and were positive for CMV via immunostaining. The patient was treated with oral valganciclovir, alongside continued proton pump inhibitors and sucralfate therapy. Discussion: This case highlights an atypical presentation of CMV esophagitis as an esophageal mass, contrasting with its more common ulcerative manifestations. In immunocompromised patients presenting with esophageal masses, CMV infection should be considered in the differential diagnosis to avoid misdiagnosis with malignancy or other conditions. Prompt and accurate diagnosis is crucial, as antiviral therapy is effective. This case underscores the importance of thorough histopathological evaluation, including CMV immunostaining, in such clinical scenarios.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 56%
Cytomegalovirus and herpesvirus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.